Zoetis (ZTS) Operating Leases (2019 - 2026)
Zoetis' (ZTS) quarterly Operating Leases came in at $193.0 million in Q1 2026, up 11.56% year-on-year from $173.0 million in Q1 2025, and down 2.03% on a QoQ basis from $197.0 million in Q4 2025.
Zoetis (ZTS) Operating Leases (2019 - 2026) Analysis & Trends
Zoetis (ZTS) has 8 years of Operating Leases data on file, last reported at $193.0 million in Q1 2026.
- On a quarterly basis, Operating Leases rose 11.56% year-over-year to $193.0 million in Q1 2026; TTM through Mar 2026 was $193.0 million, a 11.56% increase from a year earlier, with the FY2025 full-year figure at $197.0 million, up 13.22% from the prior year.
- Operating Leases for Q1 2026 stood at $193.0 million, down from $197.0 million in the prior quarter.
- Over the last five years, Operating Leases for ZTS reached as high as $229.0 million in Q4 2022 and fell as low as $158.0 million in Q1 2022.
- Historically, Operating Leases has averaged $186.9 million across 5 years, with a median of $186.0 million in 2022.
- Across the five-year window, Operating Leases rose 19.27% in 2022 and slipped 17.9% in 2023, its largest moves.
- Year by year, Operating Leases stood at $229.0 million in 2022, then declined by 17.9% to $188.0 million in 2023, then decreased by 7.45% to $174.0 million in 2024, then climbed by 13.22% to $197.0 million in 2025, then dropped by 2.03% to $193.0 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $193.0 million in Q1 2026, $197.0 million in Q4 2025, and $204.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.00 Mn |
| Dec 31, 2025 | 197.00 Mn |
| Sep 30, 2025 | 204.00 Mn |
| Jun 30, 2025 | 210.00 Mn |
| Mar 31, 2025 | 173.00 Mn |
| Dec 31, 2024 | 174.00 Mn |
| Sep 30, 2024 | 181.00 Mn |
| Jun 30, 2024 | 181.00 Mn |
| Mar 31, 2024 | 184.00 Mn |
| Dec 31, 2023 | 188.00 Mn |
| Sep 30, 2023 | 191.00 Mn |
| Jun 30, 2023 | 188.00 Mn |
| Mar 31, 2023 | 180.00 Mn |
| Dec 31, 2022 | 229.00 Mn |
| Sep 30, 2022 | 186.00 Mn |
| Jun 30, 2022 | 161.00 Mn |
| Mar 31, 2022 | 158.00 Mn |
| Dec 31, 2021 | 192.00 Mn |
| Sep 30, 2021 | 160.00 Mn |
| Jun 30, 2021 | 147.00 Mn |